Ischemia Technologies gets Japanese investment
This article was originally published in Clinica
Executive Summary
Ischemia Technologies, a US company developing an early test for cardiac ischaemia before a heart attack, has signed a deal with Japanese cardiac distributor and manufacturer Goodman. Ischemia will receive $2.5 million in equity funding and Goodman will get a six-year exclusive distribution agreement for Japan.